Literature DB >> 2215357

Alteration of collagen composition and cross-linking in keloid tissues.

P E Di Cesare1, D T Cheung, N Perelman, E Libaw, L Peng, M E Nimni.   

Abstract

Collagen composition and cross-linking in human keloid and normal skin tissues were analyzed biochemically. CNBr peptides were separated by 2-dimensional (2-D) mapping and high performance liquid chromatography (HPLC). The amounts of type I and type III collagen was quantified by 2-D scanning densitometry of fluorographs of 2-D maps derived from samples radioactively labelled in vitro by [3H]-NaBH4 in dimethylformamide. Keloid tissues contained 31.6 +/- 2.2 percent type III collagen as compared to 21.4 +/- 2.7 percent type III present in normal human skin dermis. HPLC profiles of CNBr peptides showed that approximately 5 percent of the high molecular weight material in keloids is mercaptoethanol reducible, compared to insignificant amounts in normal skin. 2-D maps derived from CNBr peptides of keloid collagen demonstrated thiol reduction sensitive alpha 1(III)-CB9 dimer as well as 24,000- and 32,000-dalton CNBr peptides, which were not mercaptoethanol reduction sensitive in normal skin due to cross-linking via the lysyl oxidase pathway. Also, a group of 20,000- to 25,000-dalton CNBr peptides, in the alpha 1(I)-CB6 cross-linking region were prominent in keloid tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215357     DOI: 10.1016/s0934-8832(11)80166-6

Source DB:  PubMed          Journal:  Matrix        ISSN: 0934-8832


  6 in total

1.  Detection of lysyl oxidase gene expression in rat skin during wound healing.

Authors:  H Fushida-Takemura; M Fukuda; N Maekawa; M Chanoki; H Kobayashi; N Yashiro; M Ishii; T Hamada; S Otani; A Ooshima
Journal:  Arch Dermatol Res       Date:  1996       Impact factor: 3.017

2.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

3.  Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens.

Authors:  Gisele V Oliveira; Hal K Hawkins; David Chinkes; Ann Burke; Andre Luiz Pasqua Tavares; Marcia Ramos-e-Silva; Thomas B Albrecht; Gregory T Kitten; David N Herndon
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

4.  Bone Marrow Stem/Progenitor Cells Attenuate the Inflammatory Milieu Following Substitution Urethroplasty.

Authors:  Joceline S Liu; Matthew I Bury; Natalie J Fuller; Renea M Sturm; Nida Ahmad; Arun K Sharma
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

5.  In Situ Cytokine Expression and Morphometric Evaluation of Total Collagen and Collagens Type I and Type III in Keloid Scars.

Authors:  Isabela Rios da Silva; Luciana Colombo Rodrigues da Cunha Tiveron; Marcos Vinicius da Silva; Alberto Borges Peixoto; Carla Aparecida Xavier Carneiro; M A Dos Reis; Pedro Carvalho Furtado; Bárbara Rocha Rodrigues; Virmondes Rodrigues; Denise Bertulucci Rocha Rodrigues
Journal:  Mediators Inflamm       Date:  2017-05-30       Impact factor: 4.711

6.  Effect of Wubeizi ointment aqueous solution on the expression of type I and III procollagen genes in keloid fibroblasts.

Authors:  Xiao-Xiang Zhai; Ji-Cun Ding; Zhi-Ming Tang; Jing-Guo Li; Xiang-Hui Chen; Cui-Xia Zhang
Journal:  Exp Ther Med       Date:  2016-12-30       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.